Medicare Enrolled

Dr. Natasha Demattos, M.D.

Neurology · Spokane Valley, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1212 N PINES RD, Spokane Valley, WA 99206
5098938140
In practice since 2007 (19 years)
NPI: 1922217678 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Demattos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Demattos? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Demattos

Dr. Natasha Demattos is a neurology specialist in Spokane Valley, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Demattos performed 16,160 Medicare services across 441 unique beneficiaries.

Between the years covered by Open Payments, Dr. Demattos received a total of $23,978 from 62 pharmaceutical and/or device companies across 882 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Demattos is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 5% volume in WA $23,978 industry payments

Medicare Practice Summary

Medicare Utilization ↗
16,160
Medicare services
Top 5% in WA for neurology
441
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~851 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
15,410 $5 $7
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
554 $83 $273
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
121 $102 $347
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
54 $95 $460
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
21 $128 $337
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,978
Total received (2018-2024)
Avg $3,425/year across 7 years
Top 11% in WA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
882
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,775 (57.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,203 (42.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,065
2023
$3,416
2022
$11,222
2021
$3,026
2020
$1,619
2019
$1,422
2018
$1,209

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$277
ABBVIE INC.
$265
Teva Pharmaceuticals USA, Inc.
$235
Lilly USA, LLC
$227
EMD Serono, Inc.
$173
Eisai Inc.
$124
Boston Scientific Corporation
$109
Amneal Pharmaceuticals LLC
$89
ANI Pharmaceuticals, Inc.
$63
PFIZER INC.
$57
Merz Pharmaceuticals, LLC
$52
ARGENX US, INC.
$45
BANNER LIFE SCIENCES, LLC
$44
Neurocrine Biosciences, Inc.
$40
Otsuka America Pharmaceutical, Inc.
$39
Genentech USA, Inc.
$31
CSL Behring
$30
Novartis Pharmaceuticals Corporation
$27
Acorda Therapeutics, Inc
$24
Lundbeck LLC
$24
ACADIA Pharmaceuticals Inc
$21
Biogen, Inc.
$21
Vanda Pharmaceuticals Inc.
$20
SK Life Science, Inc.
$15
Alexion Pharmaceuticals, Inc.
$14
Top 3 companies account for 37.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$9,203
Celgene Corporation
$1,746
AbbVie Inc.
$1,325
Teva Pharmaceuticals USA, Inc.
$659
Lilly USA, LLC
$656
Amneal Pharmaceuticals LLC
$625
EMD Serono, Inc.
$618
Biogen, Inc.
$600
Biohaven Pharmaceuticals, Inc.
$511
Novartis Pharmaceuticals Corporation
$506
E.R. Squibb & Sons, L.L.C.
$485
Amgen Inc.
$461
Sunovion Pharmaceuticals Inc.
$445
Supernus Pharmaceuticals, Inc.
$440
Lundbeck LLC
$404
Neurocrine Biosciences, Inc.
$347
Biohaven Pharmaceutical Holding Company Ltd.
$323
PFIZER INC.
$321
Avanir Pharmaceuticals, Inc.
$305
Allergan, Inc.
$221
Boston Scientific Corporation
$198
Kyowa Kirin, Inc.
$191
ARGENX US, INC.
$186
Acorda Therapeutics, Inc
$184
Upsher-Smith Laboratories LLC
$169
Alexion Pharmaceuticals, Inc.
$165
SK Life Science, Inc.
$165
Eisai Inc.
$163
Mallinckrodt LLC
$155
GENZYME CORPORATION
$153
Sumitomo Pharma America, Inc.
$143
Merz Pharmaceuticals, LLC
$137
Allergan Inc.
$126
US WorldMeds, LLC
$122
Xeris Pharmaceuticals, Inc.
$121
ANI Pharmaceuticals, Inc.
$111
Genentech USA, Inc.
$102
UCB, Inc.
$101
ACADIA Pharmaceuticals Inc
$100
BANNER LIFE SCIENCES, LLC
$88
UPSHER-SMITH LABORATORIES LLC
$85
Otsuka America Pharmaceutical, Inc.
$84
Mallinckrodt Hospital Products Inc.
$76
Impax Laboratories, Inc.
$69
MDD US Operations, LLC
$67
Strongbridge US INC.
$55
GE HealthCare
$47
Medtronic USA, Inc.
$44
Banner Life Sciences, LLC
$43
HARMONY BIOSCIENCES LLC
$43
GE HEALTHCARE
$35
Ipsen Biopharmaceuticals, Inc
$33
CSL Behring
$30
LivaNova USA, Inc.
$24
MERZ NORTH AMERICA, INC.
$23
Adamas Pharmaceuticals, Inc.
$22
AbbVie, Inc.
$22
Vanda Pharmaceuticals Inc.
$20
JAZZ PHARMACEUTICALS INC.
$19
Otsuka Pharmaceutical Development & Commercialization, Inc.
$18
Harmony Biosciences LLC
$18
Exeltis, USA Inc.
$17
Top 3 companies account for 51.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Bionic Navigator · Briviact · CHANTIX · CREXONT · DAYBUE · Dysport · EMGALITY · Enspryng · GENERAL DBS · GILENYA · GOCOVRI · GVOKE PFS · General - DBS · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · ONGENTYS · Ocrevus · Ocrevus Zunovo · Ongentys · PAXLOVID · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RYTARY · Rebif · SOLIRIS · SPECTRA WAVEWRITER · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XEOMIN · XYWAV · Xadago · Xeomin · ZEPOSIA · ZERIT · Zembrace SymTouch Sumatriptan Injection · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (57%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Spokane Valley?
Compare neurologists in the Spokane Valley area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
29
Per 100K population
5.3
County median income
$73,513
Nearest hospital
MULTICARE VALLEY HOSPITAL
4.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Demattos is a mixed practice specialist, with above-average Medicare volume (top 5% in WA), with low-engagement industry engagement in the top 11% of WA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Demattos experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Demattos performed 15,410 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Demattos receive payments from pharmaceutical companies?
Yes. Dr. Demattos received a total of $23,978 from 62 companies across 882 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Demattos's costs compare to other neurologists in Spokane Valley?
Dr. Demattos's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Demattos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →